When compared with placebo, vunakizumab is a safe and efficacious treatment for moderate to severe plaque psoriasis among adults.

During August 2021 to August 2023, the prevalence of adult hypertension was 47.7 percent, with hypertension higher in men than women.

Higher adherence to American dietary guideline recommendations may be associated with a lower risk for grade reclassification in men diagnosed with grade group 1 (GG1) prostate cancer.

A study of patients with cancer found opioid-induced constipation management is inadequate, despite available evidence-based strategies and interventions.

Offspring of mothers with an eating disorder or prepregnancy body mass index (BMI) outside the normal weight range have an increased risk for psychiatric disorders.

Selarsdi (ustekinumab-aekn), a biosimilar to Stelara (ustekinumab), is expanded to the indications to include treatment of Crohn disease ...

HealthDay News — Patients with psychiatric disorders have an increased rate of sudden cardiac death (SCD), according to a study published online Oct. 22 in Heart.

HealthDay News — Urban green spaces appear to play an important role in mitigating heat-related health risks, according to a review published online Oct. 22 in BMJ Open.

Long-term exposure to inorganic arsenic in drinking water (wAs) from U.S. community water supplies (CWS) at levels below the federal maximum contaminant level of 10 µg/L is associated with an ...

Treatment with bimekizumab yields significant and rapid improvements in patient-reported symptoms and enhanced HRQOL among individuals with PsA.

Secukinumab is safe and effective over a 48-month period among patients with PsA, demonstrating sustained disease control and high drug retention rates.

Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have an increased risk for breast cancer. HealthDay News — Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have ...